INS and Hyperglycemia: Multiple reports have demonstrated that human pseudoislets contain more insulin, perform better than native islets in glucose-stimulated insulin secretion (GSIS) in vitro and improve hyperglycemia in vivo when transplanted in mice [6,7,17].